botulinum toxin A abobotulinumtoxinA
Selected indexed studies
- Botulinum toxin type A for facial wrinkles. (Cochrane Database Syst Rev, 2021) [PMID:34224576]
- Botulinum toxin type A therapy for cervical dystonia. (Cochrane Database Syst Rev, 2020) [PMID:33180963]
- Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis. (J Am Acad Dermatol, 2020) [PMID:31811879]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Botulinum toxin type A for facial wrinkles. (2021) pubmed
- Botulinum toxin type A therapy for cervical dystonia. (2020) pubmed
- Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review. (2023) pubmed
- Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis. (2020) pubmed
- Comparison of Botulinum Toxin A Formulations for Glabellar Strain Treatment in Women: A Double-Blind Randomized Clinical Trial. (2025) pubmed
- Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice. (2016) pubmed
- Botulinum Toxin Type A Immunogenicity across Multiple Indications: An Overview Systematic Review. (2022) pubmed
- Exploring Nonresponse to Botulinum Toxin in Aesthetics: Narrative Review of Key Trigger Factors and Effective Management Strategies. (2025) pubmed
- Botulinum toxin type A versus anticholinergics for cervical dystonia. (2021) pubmed
- Botulinum toxin type A therapy for cervical dystonia. (2017) pubmed